Gilotrif 30 mg/1 (Afatinib TABLET, FILM COATED) 30 mg/1

Gilotrif 30 mg tablets are a pharmaceutical product used for targeted therapy. This medication is designed to help manage specific types of cancer, offering a precise approach to treatment.

Strength

30 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0597-0137-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gilotrif 30 mg tablets are primarily used in the treatment of certain types of cancer. This medication targets specific proteins involved in cancer cell growth, aiming to inhibit their activity. Patients often wonder, 'What is Gilotrif used for?' It is typically prescribed for advanced or metastatic non-small cell lung cancer with specific genetic markers.

Side Effects

Common effects of Gilotrif 30 mg tablets may include skin rash, diarrhea, and fatigue. Some users might experience nausea or loss of appetite. These effects can vary from person to person, and it's important to monitor any changes while using this medication.

Precautions & Warnings

Gilotrif 30 mg tablets should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and report any severe reactions promptly.

Avoid Interactions

Gilotrif 30 mg tablets may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of this medication.

Frequently Asked Questions

Gilotrif is used for the treatment of specific types of cancer, particularly non-small cell lung cancer with certain genetic markers.

Gilotrif is typically taken orally, usually once daily. Follow the specific instructions provided by your healthcare professional.

Common side effects may include skin rash, diarrhea, fatigue, nausea, and loss of appetite.

Gilotrif may interact with other medications, so it's important to consult your healthcare provider before combining it with other treatments.

Long-term use of Gilotrif should be monitored by a healthcare professional to manage potential side effects and ensure efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.